Search Constraints
« Previous |
21 - 40 of 81
|
Next »
Search Results
Select an image to start the slideshow
Structure-guided approaches to the design of novel autotaxin inhibitors
1 of 20
Investigating and exploiting best practices in hit identification and hit to lead chemistry
2 of 20
Pharmacological characterisation of the 5-HT receptors present on mouse and human hepatic stellate cells and their role in liver fibrosis
3 of 20
The design and synthesis of small molecule bromodomain inhibitors
4 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
5 of 20
Understanding reaction mechanisms and structure/reactivity relationships in the electrophilic fluorination of enol esters
6 of 20
Increasing the saturation of BET inhibitors
7 of 20
Computational modelling of enzyme activity to speed up biocatalyst redesign
8 of 20
Iron-catalysed cross-couplings of secondary alkyl Grignard reagents
9 of 20
The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles
10 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
11 of 20
Chemoselective C-H functionalisation of aliphatic azacycles : utilisation of electrophilic iodine as a mild oxidant
12 of 20
Chan-Lam animation studies : solving the chemotype reactivity issue
13 of 20
Development towards prospective modelling of in vivo rabbit QTc prolongation
14 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
15 of 20
Studies towards the synthesis and labelling of bioactive peptides
16 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
17 of 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
18 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
19 of 20
Development of lysine-targeted irreversible inhibitors of PI3Kδ
20 of 20